Harpoon Therapeutics Inc.

NASDAQ: HARP · Real-Time Price · USD
23.01
0.02 (0.09%)
At close: Mar 08, 2024, 10:00 PM

Harpoon Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-67.73M -116.72M
Depreciation & Amortization
2.36M 2.19M
Stock-Based Compensation
8.64M 9.46M
Other Working Capital
-35.63M -20.45M
Other Non-Cash Items
1.13M 456K
Deferred Income Tax
n/a 2.37M
Change in Working Capital
-33.58M -19.91M
Operating Cash Flow
-89.18M -122.15M
Capital Expenditures
-347K -100K
Cash Acquisitions
-89.74M n/a
Purchase of Investments
-24.43M -151.97M
Sales Maturities Of Investments
114.51M 186.42M
Other Investing Acitivies
89.74M n/a
Investing Cash Flow
89.74M 34.35M
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
6.37M 111.52M
Financial Cash Flow
6.37M 111.52M
Net Cash Flow
6.93M 23.72M
Free Cash Flow
-89.53M -122.25M